PPARD and breast carcinoma: Contradictory results have also been published for breast cancer cell lines, reporting both PPAR-δ-dependent inhibition of proliferation and tumorigenicity [41], and proliferative, survival, and metastatic advantages in normal and harsh metabolic conditions [42].